Literature DB >> 6239872

Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus.

K G Chandy, A M Charles, A Kershnar, B Buckingham, N Waldeck, S Gupta.   

Abstract

The autologous mixed lymphocyte response (AMLR) and the allogeneic mixed lymphocyte response were deficient in a subset of patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Using a single set of HLA-identical twins, the cellular and molecular basis of deficient AMLR was investigated and appears to be due to a defect in both responder T cells and stimulator non-T cells. Interleukin-2 production was diminished in the patient but not in the healthy twin. The in vitro addition of purified interleukin-2 enhanced the depressed AMLR in the diseased twin. This suggests that the deficient AMLR in IDDM may be in part due to a deficiency in the production of interleukin-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239872     DOI: 10.1007/bf00916571

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 2.  The role of the human major histocompatibility complex in cytotoxic T-cell responses to virus-infected cells.

Authors:  W E Biddison
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

Review 3.  The autologous mixed-lymphocyte reaction.

Authors:  M E Weksler; C E Moody; R W Kozak
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

4.  HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction.

Authors:  R Palacios; G Möller
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

Review 5.  Circulating immune complexes in diabetes.

Authors:  U Di Mario; M Iavicoli; D Andreani
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

6.  Adrenal autoantibodies and Addison disease in insulin-dependent diabetes mellitus.

Authors:  W J Riley; N K Maclaren; M Neufeld
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

7.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

Review 8.  Autologous mixed lymphocyte reaction in health and disease states in man.

Authors:  S Gupta
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

9.  Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus.

Authors:  K G Chandy; M A Charles; B Buckingham; N Waldeck; A Kershnar; S Gupta
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

10.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

3.  Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Authors:  L Räsänen; H Hyöty; M Lehto; O P Kallioniemi; J Antonen; T Huupponen; J Karjalainen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  The effect of zinc status on the immune function of diabetic rats.

Authors:  A D Mooradian; D C Norman; J E Morley
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

5.  Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

Authors:  R L Hirsch
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 6.  Self-nonself discrimination and tolerance in T and B lymphocytes.

Authors:  J F Miller
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 7.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

8.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 10.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.